Ferroptosis: action and mechanism of chemical/drug-induced liver injury.

Chemical or drug induced liver injury GPX4 antitubercular agents ferroptosis glutathione reactive oxygen species

Journal

Drug and chemical toxicology
ISSN: 1525-6014
Titre abrégé: Drug Chem Toxicol
Pays: United States
ID NLM: 7801723

Informations de publication

Date de publication:
26 Dec 2023
Historique:
medline: 27 12 2023
pubmed: 27 12 2023
entrez: 27 12 2023
Statut: aheadofprint

Résumé

Drug-induced liver injury (DILI) is characterized by hepatocyte injury, cholestasis injury, and mixed injury. The liver transplantation is required for serious clinical outcomes such as acute liver failure. Current studies have found that many mechanisms were involved in DILI, such as mitochondrial oxidative stress, apoptosis, necroptosis, autophagy, ferroptosis, etc. Ferroptosis occurs when hepatocytes die from iron-dependent lipid peroxidation and plays a key role in DILI. After entry into the liver, where some drugs or chemicals are metabolized, they convert into hepatotoxic substances, consume reduced glutathione (GSH), and decrease the reductive capacity of GSH-dependent GPX4, leading to redox imbalance in hepatocytes and increase of reactive oxygen species (ROS) and lipid peroxidation level, leading to the undermining of hepatocytes; some drugs facilitated the autophagy of ferritin, orchestrating the increased ion level and ferroptosis. The purpose of this review is to summarize the role of ferroptosis in chemical- or drug-induced liver injury (chemical/DILI) and how natural products inhibit ferroptosis to prevent chemical/DILI.

Identifiants

pubmed: 38148561
doi: 10.1080/01480545.2023.2295230
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-12

Auteurs

Li Zeng (L)

Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, College of Basic Medical Sciences, China Three Gorges University, Yichang, China.
Institute of Infection and Inflammation, College of Basic Medical Sciences, China Three Gorges University, Yichang, China.

Xueli Jin (X)

Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, College of Basic Medical Sciences, China Three Gorges University, Yichang, China.
Institute of Infection and Inflammation, College of Basic Medical Sciences, China Three Gorges University, Yichang, China.

Qing-Ao Xiao (QA)

Department of Interventional Radiology, the First College of Clinical Medical Science, China Three Gorges University, Yichang, China.
Yichang Central People's Hospital, Yichang, China.

Wei Jiang (W)

Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, College of Basic Medical Sciences, China Three Gorges University, Yichang, China.
Institute of Infection and Inflammation, College of Basic Medical Sciences, China Three Gorges University, Yichang, China.

Shanshan Han (S)

Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, College of Basic Medical Sciences, China Three Gorges University, Yichang, China.
Institute of Infection and Inflammation, College of Basic Medical Sciences, China Three Gorges University, Yichang, China.

Jin Chao (J)

Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, College of Basic Medical Sciences, China Three Gorges University, Yichang, China.
Institute of Infection and Inflammation, College of Basic Medical Sciences, China Three Gorges University, Yichang, China.

Ding Zhang (D)

Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, College of Basic Medical Sciences, China Three Gorges University, Yichang, China.
Institute of Infection and Inflammation, College of Basic Medical Sciences, China Three Gorges University, Yichang, China.

Xuan Xia (X)

Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, College of Basic Medical Sciences, China Three Gorges University, Yichang, China.
Institute of Infection and Inflammation, College of Basic Medical Sciences, China Three Gorges University, Yichang, China.
Department of Physiology and Pathophysiology, College of Basic Medical Sciences, China Three Gorges University, Yichang, China.

Decheng Wang (D)

Hubei Key Laboratory of Tumor Microenvironment and Immunotherapy, College of Basic Medical Sciences, China Three Gorges University, Yichang, China.
Institute of Infection and Inflammation, College of Basic Medical Sciences, China Three Gorges University, Yichang, China.

Classifications MeSH